An announcement from Alterity Therapeutics Ltd. ( (AU:ATH) ) is now available.
JPMorgan Chase & Co. and its affiliates have become substantial holders in Alterity Therapeutics Ltd, acquiring a 5.13% voting power in the company. This acquisition signifies a notable investment by a major financial institution, potentially impacting Alterity Therapeutics’ market position and stakeholder interests.
More about Alterity Therapeutics Ltd.
Average Trading Volume: 100
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $42.1M
For an in-depth examination of ATH stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com